Brielle Benyon

Brielle Benyon, Senior Editor for CURE®, has been with MJH Life Sciences since 2016. She has served as an editor on both CURE and its sister publication, Oncology Nursing News. Brielle is a graduate from The College of New Jersey, where she is pursuing a Master’s in Public Health (part-time). Outside of work, she enjoys spending time with family and friends, CrossFit and wishing she had the grace and confidence of her toddler-aged daughter.

Follow Brielle on Twitter @Brielle_Benyon.


Blood Test Results May Offer Clues to Neurotoxicity Risk After CAR-T Cell Therapy in Cancer

September 22, 2022

Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.

Robin Roberts to Step Away from “GMA,” Former NFL Player Dies of Cancer and More

September 02, 2022

From “Good Morning America” host Robin Roberts stepping away from the show after her partner finished breast cancer radiation to a former Tampa Bay Buccaneer dying of leukemia, here is what’s happening in the cancer space this week.

Early Findings of Novel Agent Show Promise in Treating Rare Blood Cancer

August 31, 2022

Patients with blastic plasmacytoid dendritic cell neoplasms can enroll in the ongoing CADENZA trial, which is investigating the safety and efficacy of the novel agent pivekimab sunirine in patients with the rare blood cancer.